Cargando…

Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead

Animal-derived antivenoms constitute the mainstay in the therapy of snakebite envenoming. The efficacy of antivenoms to neutralize toxicity of medically-relevant snake venoms has to be demonstrated through meticulous preclinical testing before their introduction into the clinical setting. The gold s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gutiérrez, José María, Solano, Gabriela, Pla, Davinia, Herrera, María, Segura, Álvaro, Vargas, Mariángela, Villalta, Mauren, Sánchez, Andrés, Sanz, Libia, Lomonte, Bruno, León, Guillermo, Calvete, Juan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450711/ https://www.ncbi.nlm.nih.gov/pubmed/28505100 http://dx.doi.org/10.3390/toxins9050163

Ejemplares similares

Omics Meets Biology: Application to the Design and Preclinical Assessment of Antivenoms
por: Calvete, Juan J., et al.
Publicado: (2014)

Preclinical Evaluation of Caprylic Acid-Fractionated IgG Antivenom for the Treatment of Taipan (Oxyuranus scutellatus) Envenoming in Papua New Guinea
por: Vargas, Mariángela, et al.
Publicado: (2011)

Third Generation Antivenomics: Pushing the Limits of the In Vitro Preclinical Assessment of Antivenoms
por: Pla, Davinia, et al.
Publicado: (2017)

Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms
por: Mora-Obando, Diana, et al.
Publicado: (2021)

Snake Venomics and Antivenomics of Bothrops diporus, a Medically Important Pitviper in Northeastern Argentina
por: Gay, Carolina, et al.
Publicado: (2015)

Dagestan blunt-nosed viper, Macrovipera lebetina obtusa (Dwigubsky, 1832), venom. Venomics, antivenomics, and neutralization assays of the lethal and toxic venom activities by anti-Macrovipera lebetina turanica and anti-Vipera berus berus antivenoms
por: Pla, Davinia, et al.
Publicado: (2020)

In Vitro Tests for Assessing the Neutralizing Ability of Snake Antivenoms: Toward the 3Rs Principles
por: Gutiérrez, José María, et al.
Publicado: (2021)

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
por: Alirol, Emilie, et al.
Publicado: (2015)

Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria
por: Habib, Abdulrazaq G., et al.
Publicado: (2015)

Third-generation antivenomics analysis of the preclinical efficacy of Bothrofav® antivenom towards Bothrops lanceolatus venom
por: Pla, Davinia, et al.
Publicado: (2018)

Vipera berus berus Venom from Russia: Venomics, Bioactivities and Preclinical Assessment of Microgen Antivenom
por: Al-Shekhadat, Ruslan I., et al.
Publicado: (2019)

The Need for Next-Generation Antivenom for Snakebite Envenomation in India
por: Vanuopadath, Muralidharan, et al.
Publicado: (2023)

Snakebite and local envenomation by Boiruna maculata treated without antivenom
por: Terashige, Shou, et al.
Publicado: (2021)

Cross-reactivity, antivenomics, and neutralization of toxic activities of Lachesis venoms by polyspecific and monospecific antivenoms
por: Madrigal, Marvin, et al.
Publicado: (2017)

Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa
por: Hamza, Muhammad, et al.
Publicado: (2016)

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
por: Gutiérrez, José María, et al.
Publicado: (2021)

Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues
por: Potet, Julien, et al.
Publicado: (2022)

Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations
por: Adrião, Asenate A. X., et al.
Publicado: (2022)

Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations
por: Dalhat, Mahmood Muazu, et al.
Publicado: (2023)

Effect of the time to antivenom administration on recovery from snakebite envenoming-related coagulopathy in French Guiana
por: Houcke, Stéphanie, et al.
Publicado: (2023)

Antivenomics of Atropoides mexicanus and Atropoides picadoi snake venoms: Relationship to the neutralization of toxic and enzymatic activities
por: Antúnez, José, et al.
Publicado: (2010)

What killed Karl Patterson Schmidt? Combined venom gland transcriptomic, venomic and antivenomic analysis of the South African green tree snake (the boomslang), Dispholidus typus
por: Pla, Davinia, et al.
Publicado: (2017)

Death Adder Envenoming Causes Neurotoxicity Not Reversed by Antivenom - Australian Snakebite Project (ASP-16)
por: Johnston, Christopher I., et al.
Publicado: (2012)

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
por: Sharma, Sanjib Kumar, et al.
Publicado: (2019)

Antivenom access impacts severity of Brazilian snakebite envenoming: A geographic information system analysis
por: Isaacson, Julia Elizabeth, et al.
Publicado: (2023)

Venomic Analysis of the Poorly Studied Desert Coral Snake, Micrurus tschudii tschudii, Supports the 3FTx/PLA(2) Dichotomy across Micrurus Venoms
por: Sanz, Libia, et al.
Publicado: (2016)

Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal
por: Alirol, Emilie, et al.
Publicado: (2017)

New approaches & technologies of venomics to meet the challenge of human envenoming by snakebites in India
por: Warrell, David A., et al.
Publicado: (2013)

Using Geographical Information Systems to Identify Populations in Need of Improved Accessibility to Antivenom Treatment for Snakebite Envenoming in Costa Rica
por: Hansson, Erik, et al.
Publicado: (2013)

Green medicine as a harmonizing tool to antivenom therapy for the clinical management of snakebite: The road ahead
por: Mukherjee, Ashis K.
Publicado: (2012)

Clinical effects of immunization, bleeding, and albumin-based fluid therapy in horses used as immunoglobulin source to produce a polyspecific antivenom (Echitab-plus-ICP) towards venoms of African snakes
por: Huertas, Rose Mary, et al.
Publicado: (2023)

Antibiotic therapy for snakebite envenoming
por: Resiere, Dabor, et al.
Publicado: (2020)

Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
por: Durán, Gina, et al.
Publicado: (2021)

Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming — Australian Snakebite Project (ASP-14)
por: Allen, George E., et al.
Publicado: (2012)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
por: Patikorn, Chanthawat, et al.
Publicado: (2022)

The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India
por: Attarde, Saurabh, et al.
Publicado: (2022)

Snakebite envenoming from an Ecohealth perspective
por: Gutiérrez, José María
Publicado: (2020)

A transdisciplinary approach to snakebite envenoming
por: Ruiz de Castañeda, Rafael, et al.
Publicado: (2021)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020)

Antibodies as Snakebite Antivenoms: Past and Future
por: Dias da Silva, Wilmar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9harve8ed40pngrv9uuvqvn7fo